Orion Oyj
OTC: ORINF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Aino Anna Liisa Hurme
- Employees
- 3,882
- Headquarters
- Espoo, Finland
- IPO year
- 2013
- Market cap
- $11.7B
- Website
- https://www.orionpharma.com
Loading ORINF…
Loading profile data…Frequently asked questions about ORINF
What does Orion Oyj (ORINF) do?
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and lab...
Where does ORINF trade?
Orion Oyj (ORINF) trades on the Other OTC.
What sector is ORINF in?
Orion Oyj (ORINF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Orion Oyj?
Aino Anna Liisa Hurme is the chief executive officer of Orion Oyj (ORINF).
Where is Orion Oyj headquartered?
Orion Oyj is headquartered in Finland.
Does ORINF pay a dividend?
Yes — Orion Oyj (ORINF) paid a trailing twelve-month dividend of USD 2.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ORINF go public?
Orion Oyj (ORINF) completed its initial public offering in 2013.